• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Apelin-13 通过抑制 Chk1 介导的 DNA 损伤改善 LPS 诱导的急性肺损伤小鼠模型的肺上皮屏障功能。

Apelin-13 improves pulmonary epithelial barrier function in a mouse model of LPS-induced acute lung injury by inhibiting Chk1-mediated DNA damage.

机构信息

Department of Children's Respiration disease, the Second Affiliated Hospital and Yuying Children's Hospital, Wenzhou Medical University, Wenzhou 325000, Zhejiang, PR China; School of Basic Medical Sciences, Cixi Biomedical Research Institute, Wenzhou Medical University, Zhejiang 315302, PR China.

Department of Children's Respiration disease, the Second Affiliated Hospital and Yuying Children's Hospital, Wenzhou Medical University, Wenzhou 325000, Zhejiang, PR China.

出版信息

Biochem Pharmacol. 2024 Aug;226:116297. doi: 10.1016/j.bcp.2024.116297. Epub 2024 May 25.

DOI:10.1016/j.bcp.2024.116297
PMID:38801925
Abstract

Apelin-13, a type of active peptide, can alleviate lipopolysaccharide (LPS)-induced acute lung injury (ALI). However, the specific mechanism is unclear. Cell cycle checkpoint kinase 1 (Chk1) plays an important role in DNA damage. Here, we investigated the regulatory effect of Apelin on Chk1 in ALI. Chk1-knockout and -overexpression mice were used to explore the role of Chk1 in LPS-induced ALI mice treated with or without Apelin-13. In addition, A549 cells were also treated with LPS to establish a cell model. Chk1 knockdown inhibited the destruction of alveolar structure, the damage of lung epithelial barrier function, and DNA damage in the ALI mouse model. Conversely, Chk1 overexpression had the opposite effect. Furthermore, Apelin-13 reduced Chk1 expression and DNA damage to improve the impaired lung epithelial barrier function in the ALI model. However, the high expression of Chk1 attenuated the protective effect of Apelin-13 on ALI. Notably, Apelin-13 promoted Chk1 degradation through autophagy to regulate DNA damage in LPS-treated A549 cells. In summary, Apelin-13 regulates the expression of Chk1 by promoting autophagy, thereby inhibiting epithelial DNA damage and repairing epithelial barrier function.

摘要

Apelin-13 是一种活性肽,可减轻脂多糖(LPS)诱导的急性肺损伤(ALI)。然而,其具体机制尚不清楚。细胞周期检查点激酶 1(Chk1)在 DNA 损伤中发挥重要作用。在这里,我们研究了 Apelin 对 ALI 中 Chk1 的调节作用。使用 Chk1 敲除和过表达小鼠来探讨 Chk1 在 LPS 诱导的 ALI 小鼠中的作用,这些小鼠经或未经 Apelin-13 处理。此外,还使用 LPS 处理 A549 细胞建立细胞模型。Chk1 敲低抑制了 ALI 小鼠模型中肺泡结构的破坏、肺上皮屏障功能的损伤和 DNA 损伤。相反,Chk1 过表达则产生相反的效果。此外,Apelin-13 降低 Chk1 表达和 DNA 损伤,改善 ALI 模型中受损的肺上皮屏障功能。然而,Chk1 的高表达减弱了 Apelin-13 对 ALI 的保护作用。值得注意的是,Apelin-13 通过自噬促进 Chk1 降解,从而调节 LPS 处理的 A549 细胞中的 DNA 损伤。总之,Apelin-13 通过促进自噬来调节 Chk1 的表达,从而抑制上皮细胞的 DNA 损伤并修复上皮屏障功能。

相似文献

1
Apelin-13 improves pulmonary epithelial barrier function in a mouse model of LPS-induced acute lung injury by inhibiting Chk1-mediated DNA damage.Apelin-13 通过抑制 Chk1 介导的 DNA 损伤改善 LPS 诱导的急性肺损伤小鼠模型的肺上皮屏障功能。
Biochem Pharmacol. 2024 Aug;226:116297. doi: 10.1016/j.bcp.2024.116297. Epub 2024 May 25.
2
Apelin-13-Mediated AMPK ameliorates endothelial barrier dysfunction in acute lung injury mice via improvement of mitochondrial function and autophagy.Apelin-13 通过改善线粒体功能和自噬减轻急性肺损伤小鼠的内皮屏障功能障碍。
Int Immunopharmacol. 2021 Dec;101(Pt B):108230. doi: 10.1016/j.intimp.2021.108230. Epub 2021 Oct 13.
3
FTO Deficiency Alleviates LPS-induced Acute Lung Injury by TXNIP/NLRP3-mediated Alveolar Epithelial Cell Pyroptosis.FTO 缺乏通过 TXNIP/NLRP3 介导的肺泡上皮细胞焦亡减轻 LPS 诱导的急性肺损伤。
Am J Respir Cell Mol Biol. 2024 May;70(5):351-363. doi: 10.1165/rcmb.2023-0251OC.
4
APELIN-13 AMELIORATES LPS-INDUCED ENDOTHELIAL-TO-MESENCHYMAL TRANSITION AND POST-ACUTE LUNG INJURY PULMONARY FIBROSIS BY SUPPRESSING TRANSFORMING GROWTH FACTOR-Β1 SIGNALING.阿帕琳-13通过抑制转化生长因子-β1信号通路改善脂多糖诱导的内皮-间充质转化及急性肺损伤后肺纤维化
Shock. 2023 Jan 1;59(1):108-117. doi: 10.1097/SHK.0000000000002046. Epub 2022 Nov 15.
5
Apelin-13 Administration Protects Against LPS-Induced Acute Lung Injury by Inhibiting NF-κB Pathway and NLRP3 Inflammasome Activation.给予Apelin-13通过抑制NF-κB通路和NLRP3炎性小体激活来预防脂多糖诱导的急性肺损伤。
Cell Physiol Biochem. 2018;49(5):1918-1932. doi: 10.1159/000493653. Epub 2018 Sep 20.
6
Autophagy inhibition protects from alveolar barrier dysfunction in LPS-induced ALI mice by targeting alveolar epithelial cells.自噬抑制通过靶向肺泡上皮细胞保护 LPS 诱导的 ALI 小鼠的肺泡屏障功能障碍。
Respir Physiol Neurobiol. 2021 Jan;283:103532. doi: 10.1016/j.resp.2020.103532. Epub 2020 Sep 18.
7
USP9X promotes LPS-induced pulmonary epithelial barrier breakdown and hyperpermeability by activating an NF-κBp65 feedback loop.USP9X 通过激活 NF-κBp65 反馈环促进 LPS 诱导的肺上皮屏障破坏和高通透性。
Am J Physiol Cell Physiol. 2019 Sep 1;317(3):C534-C543. doi: 10.1152/ajpcell.00094.2019. Epub 2019 Jun 19.
8
WWOX activates autophagy to alleviate lipopolysaccharide-induced acute lung injury by regulating mTOR.WWOX通过调节mTOR激活自噬以减轻脂多糖诱导的急性肺损伤。
Int Immunopharmacol. 2023 Feb;115:109671. doi: 10.1016/j.intimp.2022.109671. Epub 2023 Jan 6.
9
Regulation of alveolar procoagulant activity and permeability in direct acute lung injury by lung epithelial tissue factor.肺上皮组织因子对直接急性肺损伤中肺泡促凝活性和通透性的调节作用
Am J Respir Cell Mol Biol. 2015 Nov;53(5):719-27. doi: 10.1165/rcmb.2014-0179OC.
10
Peiminine Attenuates Acute Lung Injury Induced by LPS Through Inhibiting Lipid Rafts Formation.佩米诺林通过抑制脂筏形成来减轻 LPS 诱导的急性肺损伤。
Inflammation. 2020 Jun;43(3):1110-1119. doi: 10.1007/s10753-020-01198-w.

引用本文的文献

1
Checkpoint kinase 1 in colorectal cancer: Upregulation of expression and promotion of cell proliferation.结直肠癌中的检查点激酶1:表达上调与细胞增殖促进
World J Clin Oncol. 2025 Mar 24;16(3):101725. doi: 10.5306/wjco.v16.i3.101725.
2
Analysis of Biomarker Levels in Nasopharyngeal Swabs, Serum, and Saliva Across Different Health Conditions.不同健康状况下鼻咽拭子、血清和唾液中生物标志物水平的分析。
Life (Basel). 2025 Feb 19;15(2):324. doi: 10.3390/life15020324.
3
Process-Specific Blood Biomarkers and Outcomes in COVID-19 Versus Non-COVID-19 ARDS (APEL-COVID Study): A Prospective, Observational Cohort Study.
新型冠状病毒肺炎与非新型冠状病毒肺炎急性呼吸窘迫综合征的特定病程血液生物标志物及预后(APEL-COVID研究):一项前瞻性观察性队列研究
J Clin Med. 2024 Oct 4;13(19):5919. doi: 10.3390/jcm13195919.